Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine versus interpersonal and social rhythm therapy for bipolar II disorder with rhythm disturbance
ChiCTR2600133600Phase 2Not yet recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of quetiapine in Bipolar II disorder (BP-II) (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Hamilton Depression Scale (17-items) total score change at 12 weeks. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
quetiapine
03
Conditions
Bipolar II disorder (BP-II)
Beyond the preview
Go deeper on ChiCTR2600133600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133600.